Why we funded it
The results of this project should help us find out which
incontinence management product, or combination of products,
performs better. Dr Fader hopes this will provide more effective
treatment choices for men managing urinary incontinence after
prostate cancer surgery.
A trial of devices for intractable urinary incontinence
following prostate cancer surgery.
Research project summary
The project will carry out a clinical trial of devices for
managing urinary incontinence (leakage from the bladder) in men who
have persistent leakage after prostate surgery for cancer.
Around 10-15% of men experience persistent urinary incontinence
after surgical removal of the prostate. This incontinence can be
very distressing and is known to have a profoundly negative effect
on men's lives, often affecting social activities, personal
relationships and mental well-being. Most men are provided with
absorbent pads to contain their incontinence (they are easy for
nurses to prescribe and do not require any skilled fitting) but
these have disadvantages and men often find larger pads to be
bulky, feminine or babyish.
The study invites men who have had prostate cancer surgery and
who are currently using absorbent pads to test three male devices
(described in detail below) in a random order and after expert
fitting. Each participant will test each device for up to two weeks
and then complete a questionnaire on product performance which has
been tested and used before in other trials. Participants will also
be asked to complete the questionnaires for their usual absorbent
pads. The most important outcome will be the 'overall opinion' of
the device/pad, and (after testing all the devices) preference for
each (for different situations/circumstances) when compared to the
other devices and the usual absorbent pad. In addition we will
measure whether use of the devices improves quality of life.
The trial will take two years to complete. It will provide new
information about the effectiveness of male devices and absorbent
pads for the management of persistent incontinence following
prostate cancer surgery, and the effects on quality of life. This
evidence will enable nursing and continence services to provide
better services and optimum continence products to such men and
will help the Prostate Cancer Charity and other charities such as
the Bladder and Bowel Foundation to provide appropriate product
advice, support and information to men with prostate cancer and
Read more about the 3 devices to be tested here.